Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

eukaryotic translation initiation factor 4E binding protein 2, Mouse, Clone: 2G8, Abnova™

Mouse monoclonal antibody raised against a partial recombinant EIF4EBP2.

Supplier:  Abnova Corporation H00001979M04

Catalog No. 89-000-621


Only null left
Add to Cart

Description

Description

This gene encodes a member of the eukaryotic translation initiation factor 4E binding protein family. The gene products of this family bind eIF4E and inhibit translation initiation. However, insulin and other growth factors can release this inhibition via a phosphorylation-dependent disruption of their binding to eIF4E. Regulation of protein production through these gene products have been implicated in cell proliferation, cell differentiation and viral infection. [provided by RefSeq

Sequence: DRRNSPMAQTPPCHLPNIPGVTSPGTLIEDSKVEVNNLNNLNNHDRKHAVGDDAQFEMDI
Specifications

Specifications

eukaryotic translation initiation factor 4E binding protein 2
Monoclonal
Unconjugated
PBS with no preservative; pH 7.4
NM_004096
EIF4EBP2
EIF4EBP2 (NP_004087, 61 a.a. ∼ 120 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
100 μg
Yes
1979
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
IgG2a κ
ELISA, Western Blot
2G8
Mouse monoclonal antibody raised against a partial recombinant EIF4EBP2.
EIF4EBP2
4EBP2/PHASII
Mouse
Affinity Purified
RUO
Primary
Human
Antibody
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.